Oncimmune Holdings plc (AIM: ONC)
London
· Delayed Price · Currency is GBP · Price in GBX| Market Cap | 17.71M |
| Revenue (ttm) | 1.21M |
| Net Income (ttm) | 7.12M |
| Shares Out | 74.10M |
| EPS (ttm) | 0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,076 |
| Open | 24.65 |
| Previous Close | 23.90 |
| Day's Range | 23.20 - 24.65 |
| 52-Week Range | 9.35 - 31.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 11, 2024 |
About Oncimmune Holdings
Oncimmune Holdings plc, a precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally. It offers ImmunoINSIGHTS, an autoantibody profiling service that unlocks the immune system to discover and convert autoantibodies into actionable biomarkers; Sero Tag, a discovery engine which identifies relevant biomarker pool for target discovery or companion diagnostics; NavigAID, a creation of a disease-specific biomarker panel; and Autoantibody Biomarkers, a c... [Read more]
Financial Performance
Financial StatementsNews
Three Quick Facts: Rightmove, Oncimmune, Vertu Motors
Rightmove, Oncimmune, Vertu Motors are Tony Cross's three picks from today's financial market news
Small Cap Stocks: Global Petroleum, Oncimmune
Global Petroleum, Oncimmune, Sunda Energy, Celadon Pharmaceuticals and Bivictrix Therapeutics are the biggest Small Cap stock movers